OPTIM Trial: A Phase III Trial of an Oncolytic Herpes Virus Encoding GM-CSF for Unresectable Stage III or IV Melanoma
Year: 2010
Type: article
Source: Future Oncology
DOI: 10.2217/fon.10.66
Authors: Howard L Kaufman, Steven D Bines
Institutions: Rush University Medical Center, Rush University
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2165038732
